Authors/Disclosures
|
Korak Sarkar, MD, MHDS, FAAN
(Ochsner Health)
|
An immediate family member of Dr. Sarkar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Canon Medical. Dr. Sarkar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medical-legal cases. Dr. Sarkar has a non-compensated relationship as a Senior Editor with Journal of Medical Extended Reality that is relevant to AAN interests or activities. |
|
Colin M. Roberts, MD
(Pediatric Neurology CDRC-P)
|
No disclosure on file |
|
Rachel A. Kuperman, MD
(Children's Hospital Oakland)
|
No disclosure on file |
|
|
No disclosure on file |
|
Mary Kay Koenig, MD
(University of Texas Health Science Center-Houston)
|
Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals. |
|
Joyce Y. Wu, MD
(Lurie Children's Hospital)
|
Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Marinus. The institution of Dr. Wu has received research support from National Institutes of Health. Dr. Wu has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. |
|
Michael H. Kohrman, MD
|
No disclosure on file |
|
Paolo Curatolo
(Hotelplan)
|
No disclosure on file |
|
Pavnit Kukreja, PharmD
(AbbVie)
|
Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie. |
|
|
No disclosure on file |
|
Noah Berkowitz
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
David N. Franz, MD
(CCHMC/MLC 2015)
|
No disclosure on file |